Department of Pathophysiology, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China.
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Nanjing, China.
Nat Commun. 2024 May 21;15(1):4340. doi: 10.1038/s41467-024-48708-0.
Macrophage-orchestrated inflammation contributes to multiple diseases including sepsis. However, the underlying mechanisms remain to be defined clearly. Here, we show that macrophage TP53-induced glycolysis and apoptosis regulator (TIGAR) is up-regulated in murine sepsis models. When myeloid Tigar is ablated, sepsis induced by either lipopolysaccharide treatment or cecal ligation puncture in male mice is attenuated via inflammation inhibition. Mechanistic characterizations indicate that TIGAR directly binds to transforming growth factor β-activated kinase (TAK1) and promotes tumor necrosis factor receptor-associated factor 6-mediated ubiquitination and auto-phosphorylation of TAK1, in which residues 152-161 of TIGAR constitute crucial motif independent of its phosphatase activity. Interference with the binding of TIGAR to TAK1 by 5Z-7-oxozeaenol exhibits therapeutic effects in male murine model of sepsis. These findings demonstrate a non-canonical function of macrophage TIGAR in promoting inflammation, and confer a potential therapeutic target for sepsis by disruption of TIGAR-TAK1 interaction.
巨噬细胞调控的炎症反应参与多种疾病,包括败血症。然而,其潜在的机制仍需进一步明确。在这里,我们发现巨噬细胞 TP53 诱导的糖酵解和凋亡调节剂(TIGAR)在小鼠败血症模型中上调。当髓样细胞 Tigar 被敲除时,雄性小鼠中由脂多糖处理或盲肠结扎穿刺引起的败血症通过炎症抑制得到缓解。机制特征表明,TIGAR 直接与转化生长因子β激活激酶(TAK1)结合,并促进肿瘤坏死因子受体相关因子 6 介导的 TAK1 的泛素化和自身磷酸化,其中 TIGAR 的 152-161 位残基构成了不依赖其磷酸酶活性的关键基序。通过 5Z-7-氧杂玉米黄质干扰 TIGAR 与 TAK1 的结合,在雄性小鼠败血症模型中表现出治疗效果。这些发现表明巨噬细胞 TIGAR 在促进炎症反应中具有非经典功能,并通过破坏 TIGAR-TAK1 相互作用为败血症提供了一个潜在的治疗靶点。